Sanofi Stock

Sanofi FCF per Share

The Free Cash Flow per Share of Sanofi (SAN.PA) as of Aug 12, 2026 is 7.41 EUR. In the previous year, Free Cash Flow per Share was 4.70 EUR — a change of 57.85% (higher).

FCF per Share

7.41EUR

YoY

57.85%

Last updated:

Free Cash Flow per Share of Sanofi is 2026 7.41 EUR. Free Cash Flow per Share of Sanofi was 2025 4.70 EUR. It decreases by 57.85% higher compared to the previous year.
Access this data via the Eulerpool API

Sanofi Stock analysis

What does Sanofi do? Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanofi stock

Free Cash Flow per Share of Sanofi is 7.41 EUR in 2026.

Free Cash Flow per Share of Sanofi changed from 4.70 EUR to 7.41 EUR, representing a 57.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Sanofi since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Sanofi

All Key Metrics — Sanofi